ISLAMABAD: The Higher Education Commission (HEC) on Friday said it has initiated a project to revamp its degree attestation system by integrating cutting-edge blockchain technology. “This pivotal ...

A US Navy Global Autonomous Reconnaissance Craft (GARC) maneuvers in the Atlantic Ocean during UNITAS 2025 on Sept. 23, 2025. US Navy photo ARLINGTON, Va. — A new office consolidating the development ...

RPSC declares final results for Rajasthan State & Subordinate Services Exam. Check merit list, roll numbers, categories, and PDF at rpsc.rajasthan.gov.in. RPSC RAS final Result out: The Rajasthan ...

I have experience in GIS/CAD, geodesy and geomatics, water resource, Data Processing and Cartography in petroleum production and exploration company for pipeline and marine installation and ...

The Higher Education Commission’s Education Testing Council (ETC) has announced the rescheduling of admission and recruitment tests. The Undergraduate Studies Admission Test (USAT), the Higher ...

The RPSC has announced the RAS mains result 2025, with 2,461 candidates declared successful. The mains exam was held on June 17 and 18, 2025, across multiple centres in Rajasthan in two shifts daily.

Reggae artiste Ras-I will readily admit that 2025 has been one of his best musical years yet. Earlier this year the singer’s 2020 hit single Somewhere Wonderful was selected as the official soundtrack ...

remove-circle Internet Archive's in-browser bookreader "theater" requires JavaScript to be enabled. It appears your browser does not have it turned on. Please see ...

Bain Capital agreed to sell its data centers in China to Shenzhen Dongyangguang Industry Co. in a transaction valued at about $4 billion. Shenzhen Dongyangguang, the parent of Shanghai-listed ...

Marking a historic milestone, the U.S. Coast Guard announced Monday the combined interdiction of more than 76,140 pounds of illicit narcotics. The quantity of drugs offloaded at Port Everglades is the ...

Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.